Terms: = Germ cell tumor AND BAP1, DKFZp686N04275, 8314, ENSG00000163930, Q92560, KIAA0272, hucep-6, HUCEP-13, FLJ37180, FLJ35406 AND Treatment
68 results:
1. Identification and validation of a costimulatory molecule-related signature to predict the prognosis for uveal melanoma patients.
Zhao M; Yu Y; Song Z
Sci Rep; 2024 Apr; 14(1):9146. PubMed ID: 38644411
[TBL] [Abstract] [Full Text] [Related]
2. Association between Parkinson's Disease and Cancer: New Findings and Possible Mediators.
Surguchov A; Surguchev AA
Int J Mol Sci; 2024 Mar; 25(7):. PubMed ID: 38612708
[TBL] [Abstract] [Full Text] [Related]
3. Emerging therapeutic strategies for metastatic uveal melanoma: Targeting driver mutations.
Liu XL; Run-Hua Z; Pan JX; Li ZJ; Yu L; Li YL
Pigment Cell Melanoma Res; 2024 May; 37(3):411-425. PubMed ID: 38411373
[TBL] [Abstract] [Full Text] [Related]
4. Uveal melanoma modeling in mice and zebrafish.
van den Bosch QCC; de Klein A; Verdijk RM; Kiliç E; Brosens E;
Biochim Biophys Acta Rev Cancer; 2024 Jan; 1879(1):189055. PubMed ID: 38104908
[TBL] [Abstract] [Full Text] [Related]
5. Combined Inhibition of EZH2 and FGFR is Synergistic in bap1-deficient Malignant Mesothelioma.
Badhai J; Landman N; Pandey GK; Song JY; Hulsman D; Krijgsman O; Chandrasekaran G; Berns A; van Lohuizen M
Cancer Res Commun; 2024 Jan; 4(1):18-27. PubMed ID: 38054839
[TBL] [Abstract] [Full Text] [Related]
6. tumor Profiles of Late Presentation Uveal Ring Melanoma With Novel Characteristics - A Case Series.
Lim JZ; Crawford AZ; McGhee CNJ
Invest Ophthalmol Vis Sci; 2023 Oct; 64(13):44. PubMed ID: 37889509
[TBL] [Abstract] [Full Text] [Related]
7. Characterisation of the protein expression of the emerging immunotherapy targets VISTA, LAG-3 and PRAME in primary uveal melanoma: insights from a southern French patient cohort.
Lamas NJ; Lassalle S; Martel A; Nahon-Estève S; Macocco A; Zahaf K; Lalvee S; Fayada J; Lespinet-Fabre V; Bordone O; Pedeutour F; Baillif S; Hofman P
Pathology; 2023 Dec; 55(7):929-944. PubMed ID: 37863710
[TBL] [Abstract] [Full Text] [Related]
8. Genetic insights into thymic carcinomas and thymic neuroendocrine neoplasms denote prognosis signatures and pathways.
Wang S; Gu Z; Zhu L; Han Y; Yu H; Fang W; Han B
Chin Med J (Engl); 2023 Nov; 136(22):2712-2721. PubMed ID: 37749819
[TBL] [Abstract] [Full Text] [Related]
9. Chemokine Analysis in Patients with Metastatic Uveal Melanoma Suggests a Role for CCL21 Signaling in Combined Epigenetic Therapy and Checkpoint Immunotherapy.
Sah VR; Jespersen H; Karlsson J; Nilsson LM; Bergqvist M; Johansson I; Carneiro A; Helgadottir H; Levin M; Ullenhag G; Ståhlberg A; Olofsson Bagge R; Nilsson JA; Ny L
Cancer Res Commun; 2023 May; 3(5):884-895. PubMed ID: 37377898
[TBL] [Abstract] [Full Text] [Related]
10. UVEAL MELANOMA PRESENTING AS HEPATIC METASTASIS IN A PATIENT WITH OCULODERMAL MELANOCYTOSIS.
Evans WI; Wilson MW; Bahrami A; Pappo AS; Hoehn ME
Retin Cases Brief Rep; 2023 Jul; 17(4):403-405. PubMed ID: 37364199
[TBL] [Abstract] [Full Text] [Related]
11. [RITA selectively inhibits proliferation of
Shi W; Liu X; Zhang G; Ye L; Zhou R; Li Y; Yu L
Nan Fang Yi Ke Da Xue Xue Bao; 2023 May; 43(5):710-717. PubMed ID: 37313811
[TBL] [Abstract] [Full Text] [Related]
12. In Vitro Testing of the Virus-Like Drug Conjugate Belzupacap Sarotalocan (AU-011) on Uveal Melanoma Suggests bap1-Related Immunostimulatory Capacity.
Ma S; Huis In't Veld RV; Houy A; Stern MH; Rich C; Ossendorp FA; Jager MJ
Invest Ophthalmol Vis Sci; 2023 Jun; 64(7):10. PubMed ID: 37272766
[TBL] [Abstract] [Full Text] [Related]
13. Investigating the Role of DUSP4 in Uveal Melanoma.
Aughton K; Sabat-Pospiech D; Barlow S; Coupland SE; Kalirai H
Transl Vis Sci Technol; 2022 Dec; 11(12):13. PubMed ID: 36576731
[TBL] [Abstract] [Full Text] [Related]
14. Diagnostic utility of immunohistochemistry in concordance with mRNA analysis of PRAME in the stratification of high-risk uveal melanoma patients.
Kumar N; Singh MK; Singh L; Lomi N; Meel R; Pushker N; Sen S; Kashyap S
Hum Cell; 2023 Jan; 36(1):342-352. PubMed ID: 36282437
[TBL] [Abstract] [Full Text] [Related]
15. CTLA4 , PD-1 , PD-L1 , PD-L2 , TIM-3 , TIGIT , and LAG3 DNA Methylation Is Associated With bap1 -Aberrancy, Transcriptional Activity, and Overall Survival in Uveal Melanoma.
de Vos L; Carrillo Cano TM; Zarbl R; Klümper N; Ralser DJ; Franzen A; Herr E; Gabrielpillai J; Vogt TJ; Dietrich J; Strieth S; Landsberg J; Dietrich D
J Immunother; 2022 Sep; 45(7):324-334. PubMed ID: 35862127
[TBL] [Abstract] [Full Text] [Related]
16. Medical and Surgical Care of Patients With Mesothelioma and Their Relatives Carrying germline bap1 Mutations.
Carbone M; Pass HI; Ak G; Alexander HR; Baas P; Baumann F; Blakely AM; Bueno R; Bzura A; Cardillo G; Churpek JE; Dianzani I; De Rienzo A; Emi M; Emri S; Felley-Bosco E; Fennell DA; Flores RM; Grosso F; Hayward NK; Hesdorffer M; Hoang CD; Johansson PA; Kindler HL; Kittaneh M; Krausz T; Mansfield A; Metintas M; Minaai M; Mutti L; Nielsen M; O'Byrne K; Opitz I; Pastorino S; Pentimalli F; de Perrot M; Pritchard A; Ripley RT; Robinson B; Rusch V; Taioli E; Takinishi Y; Tanji M; Tsao AS; Tuncer AM; Walpole S; Wolf A; Yang H; Yoshikawa Y; Zolondick A; Schrump DS; Hassan R
J Thorac Oncol; 2022 Jul; 17(7):873-889. PubMed ID: 35462085
[TBL] [Abstract] [Full Text] [Related]
17. bap1-defficient breast cancer in a patient with bap1 cancer syndrome.
Blatnik A; Ribnikar D; Šetrajčič Dragoš V; Novaković S; Stegel V; Grčar Kuzmanov B; Boc N; Perić B; Škerl P; Klančar G; Krajc M
Breast Cancer; 2022 Sep; 29(5):921-927. PubMed ID: 35381901
[TBL] [Abstract] [Full Text] [Related]
18. Evaluation of HSP-27, bap1, BRAF V600E, CCR7, and PD-L1 expression in uveal melanoma on enucleated eyes and metastatic liver tumors.
Ağın A; Kiratli H; Guresci S; Babaoglu B; Karakaya J; Soylemezoglu F
Int J Biol Markers; 2022 Jun; 37(2):200-209. PubMed ID: 35341390
[TBL] [Abstract] [Full Text] [Related]
19. New targeted and epigenetic therapeutic strategies for the treatment of uveal melanoma.
Wei AZ; Maniar AB; Carvajal RD
Cancer Gene Ther; 2022 Dec; 29(12):1819-1826. PubMed ID: 35236928
[TBL] [Abstract] [Full Text] [Related]
20. Targeting GNAQ/11 through PKC inhibition in uveal melanoma.
Lietman CD; McKean M
Cancer Gene Ther; 2022 Dec; 29(12):1809-1813. PubMed ID: 35181742
[TBL] [Abstract] [Full Text] [Related]
[Next]